Management Strategies for Opioid Use Disorder: Nonpharmacologic and Pharmacologic Approaches

Expert Guidance for Effective Management and Appropriate Monitoring of Patients With Pain

In this episode, Michael Weaver, MD, DFASAM, provides information on both nonpharmacologic and pharmacologic treatment options for patients with opioid use disorder. Listeners will gain an understanding of the available counseling programs and medications for opioid use disorder—methadone, buprenorphine, and naltrexone—including the patient scenarios for which each may be most appropriate. In addition, Dr Weaver emphasizes that substance use disorder is a chronic condition and that optimal treatment involves a multimodal approach.

Presenter:

Michael Weaver, MD, DFASAM
Professor
Department of Psychiatry and Behavioral Sciences
Medical Director
Center for Neurobehavioral Research on Addiction
McGovern Medical School
University of Texas Health Science Center at Houston
Houston, Texas

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see
https://bit.ly/3mgrfb9
for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the FDA.

Provided by Clinical Care Options, LLC and in partnership with the American Academy of Physical Medicine and Rehabilitation, Practicing Clinicians Exchange, and ProCE.

Link to full program:
https://bit.ly/3mcDHsi